- Home
- CRIS vs VTVT Comparison
CRIS vs VTVT Comparison
Compare CRIS & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- VTVT
- Stock Information
- Founded
- CRIS 2000
- VTVT 2015
- Country
- CRIS United States
- VTVT United States
- Employees
- CRIS N/A
- VTVT N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- CRIS Health Care
- VTVT Health Care
- Exchange
- CRIS Nasdaq
- VTVT Nasdaq
- Market Cap
- CRIS 27.5M
- VTVT 36.1M
- IPO Year
- CRIS 2000
- VTVT 2015
- Fundamental
- Price
- CRIS $3.87
- VTVT $14.68
- Analyst Decision
- CRIS Strong Buy
- VTVT Strong Buy
- Analyst Count
- CRIS 3
- VTVT 1
- Target Price
- CRIS $23.00
- VTVT $35.00
- AVG Volume (30 Days)
- CRIS 238.7K
- VTVT 15.2K
- Earning Date
- CRIS 02-06-2025
- VTVT 11-12-2024
- Dividend Yield
- CRIS N/A
- VTVT N/A
- EPS Growth
- CRIS N/A
- VTVT N/A
- EPS
- CRIS N/A
- VTVT N/A
- Revenue
- CRIS $10,259,000.00
- VTVT $1,000,000.00
- Revenue This Year
- CRIS N/A
- VTVT N/A
- Revenue Next Year
- CRIS N/A
- VTVT N/A
- P/E Ratio
- CRIS N/A
- VTVT N/A
- Revenue Growth
- CRIS 0.44
- VTVT 11011.11
- 52 Week Low
- CRIS $2.86
- VTVT $7.38
- 52 Week High
- CRIS $17.49
- VTVT $30.99
- Technical
- Relative Strength Index (RSI)
- CRIS 53.89
- VTVT 49.52
- Support Level
- CRIS $2.86
- VTVT $13.28
- Resistance Level
- CRIS $4.50
- VTVT $14.33
- Average True Range (ATR)
- CRIS 0.39
- VTVT 0.60
- MACD
- CRIS 0.09
- VTVT -0.11
- Stochastic Oscillator
- CRIS 61.59
- VTVT 64.02
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.